HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

placental ribonuclease inhibitor

RNasin, is a purified human placental ribonuclease inhibitor, known to have antiangiogenic activity through the inhibition of angiogenin and basic fibroblast growth factor
Also Known As:
RI ribonuclease inhibitor protein; RNasin, placental RNase inhibitor; cytosolic ribonuclease inhibitor protein; nuclease inhibitor, RNasin; placental RNase inhibitor; ribonuclease inhibitor (placental); ribonuclease-angiogenin inhibitor
Networked: 8 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Raines, Ronald T: 2 articles (12/2002 - 03/2002)
2. Almeida, Márcia R: 1 article (01/2020)
3. Baracat-Pereira, Maria Cristina: 1 article (01/2020)
4. Bressan, Gustavo C: 1 article (01/2020)
5. Cunha, Pricila S: 1 article (01/2020)
6. Fernandes, Kenner M: 1 article (01/2020)
7. Fietto, Juliana L R: 1 article (01/2020)
8. Magalhães-Junior, Marcos J: 1 article (01/2020)
9. Pereira, Lorena K J: 1 article (01/2020)
10. Santos, Marcus R: 1 article (01/2020)

Related Diseases

1. Neoplasms (Cancer)
2. Cholangiocarcinoma
3. Teratoma (Teratoid Tumor)
4. Neoplasm Metastasis (Metastasis)
5. Hydatidiform Mole (Molar Pregnancy)

Related Drugs and Biologics

1. Ribonucleases (Ribonuclease)
2. ribonuclease Sa3
3. ranpirnase (Pannon)
4. Proteins (Proteins, Gene)
5. Guanine Nucleotide Dissociation Inhibitors (GDIs)
6. HSP70 Heat-Shock Proteins (Heat-Shock Protein 70)
7. Complementary DNA (cDNA)
8. Biomarkers (Surrogate Marker)
9. Vimentin
10. Messenger RNA (mRNA)